Results 31 to 40 of about 37,987 (275)

Sensitivity and specificity of the Classification of Psoriatic Arthritis criteria in early psoriatic arthritis [PDF]

open access: yesArthritis & Rheumatism, 2012
AbstractObjectiveTo assess the sensitivity and specificity of the Classification of Psoriatic Arthritis (CASPAR) Study Group criteria in early psoriatic arthritis (PsA) and to compare them with the sensitivity and specificity of the Moll and Wright criteria.MethodsThe CASPAR Study Group criteria were applied to patients with early PsA (<24 months ...
Laura C, Coates   +6 more
openaire   +2 more sources

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood

open access: yesВопросы современной педиатрии, 2020
Psoriasis is chronic inflammatory skin disease that can develop at any age. Approximately 20–30% of all patients report about first rashes before the age of 18. Psoriatic arthritis is one of psoriasis comorbid conditions. Its signs can range from mild to
Nikolay N. Murashkin   +8 more
doaj   +1 more source

Methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis

open access: yesЛечащий Врач, 2021
The article provides data on the place of methotrexate in accordance with international and national recommendations 2019– 2020 in the management of patients with rheumatoid and psoriatic arthritis.
N. V. Chichasova, A. M. Lila
doaj   +1 more source

Treatment recommendations for psoriatic arthritis [PDF]

open access: yes, 2008
Objective: To develop comprehensive recommendations for the treatment of the various clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic review of the literature and from consensus opinion.
Boehncke, Wolf-Henning   +14 more
core   +3 more sources

Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study [PDF]

open access: yesScandinavian Journal of Rheumatology, 2020
Objective: This paper describes the baseline demographics, clinical characteristics, and patient-reported outcomes (PROs) according to clinical phenotype of patients with early psoriatic arthritis (PsA) for the purpose of creating a decision support system for daily clinical practice. Method: Patients with newly diagnosed PsA were included in the Dutch
F R, Kasiem   +14 more
openaire   +2 more sources

Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis [PDF]

open access: yesFrontiers in Medicine, 2021
Greater than 90% of patients with psoriatic arthritis (PsA) first develop their arthritis on a background of known psoriasis (Pso). Thus, having skin/nail Pso certainly is an important risk factor for PsA but as PsA develops in &lt;30% of those affected with Pso, the presence of Pso alone is insufficient as a means of identifying which patients ...
Stephen R. Pennington, Oliver FitzGerald
openaire   +3 more sources

Identification of a Single Nucleotide Polymorphism in NFKBIA with Different Effects on Psoriatic Arthritis and Cutaneous Psoriasis in China

open access: yesActa Dermato-Venereologica, 2018
Genome-wide association studies have recently identified a number of non-major histocompatibility complex regions associated with psoriatic arthritis.
Qing Zhao   +11 more
doaj   +1 more source

The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis

open access: yesVestnik Dermatologii i Venerologii, 2021
An increased risk of cardiovascular events has now been identified in patients with psoriatic arthritis. The chronic immune-mediated inflammation underlying psoriatic arthritis (PA) leads to the development of dyslipidemia, atherosclerosis and its ...
Zarema R. Khismatullina   +1 more
doaj   +1 more source

CLINICAL PRESENTATION OF PSORIATIC ARTHRITIS

open access: yesReumatismo, 2011
Psoriatic arthritis is a spondyloarthropathy, which occurs in patients with skin and/or nail psoriasis. Basing its characterization on morphological purposes, several types of arthritis have been described.
M. Atteno, R. Peluso, R. Scarpa
doaj   +1 more source

Secukinumab versus adalimumab for psoriatic arthritis: comparative effectiveness up to 48 weeks using a matching-adjusted indirect comparison [PDF]

open access: yes, 2018
Secukinumab and adalimumab are approved for adults with active psoriatic arthritis (PsA). In the absence of direct randomized controlled trial (RCT) data, matching-adjusted indirect comparison can estimate the comparative effectiveness in anti-tumor ...
Gandhi, Kunal   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy